Insider · CIK 1363558

Craig A Collard

CEO at Heron Therapeutics HRTX

Open-market buys0
Open-market sales0
Bought$0
Sold$0

Every trade, with what the company filed around it

Open-market buys and sales as each Form 4 states them, newest first.

How these figures work

Notes on each row are as each Form 4 states them, next to SEC Tracker's own records of the company's filings and other insiders' buys. Holding after is what the filing reports they held after the trade, with the change in their holding.

DateCompanyTradeValueHolding afterNotes
Oct 31, 2026Heron Therapeutics HRTXOption exercise 34,788 sh
4 days after the company's S-8 filed Oct 27, 2026.
939,557
4 days after the company's S-8 filed Oct 27, 2026.
Oct 31, 2026Heron Therapeutics HRTXTax withholding 8,471 sh at $0.28
4 days after the company's S-8 filed Oct 27, 2026.
$2K931,086
4 days after the company's S-8 filed Oct 27, 2026.
Oct 30, 2026Heron Therapeutics HRTXOption exercise 50,021 sh
3 days after the company's S-8 filed Oct 27, 2026.
916,950
3 days after the company's S-8 filed Oct 27, 2026.
Oct 30, 2026Heron Therapeutics HRTXTax withholding 12,181 sh at $0.28
3 days after the company's S-8 filed Oct 27, 2026.
$3K904,769
3 days after the company's S-8 filed Oct 27, 2026.
Oct 19, 2026Heron Therapeutics HRTXOption exercise 13,797 sh
20 days after the company's 8-K filed Sep 29, 2026.
870,289
20 days after the company's 8-K filed Sep 29, 2026.
Oct 19, 2026Heron Therapeutics HRTXTax withholding 3,360 sh at $0.36
20 days after the company's 8-K filed Sep 29, 2026.
$1K866,929
20 days after the company's 8-K filed Sep 29, 2026.

Open-market trades are Form 4 transaction codes P (purchase) and S (sale). Planned sales are those the filing marks as made under a Rule 10b5-1 plan. A P-code buy at the offering price within a day of the company's FWP, 424B prospectus or offering 8-K is marked Bought in the offering and left out of open-market buy counts and cluster buys. Prices and values are as stated in each Form 4. Stock prices aren't shown on this page. Not investment advice.